Access cutting-edge head and neck cancer treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.
Access head and neck cancer specialists in Birmingham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related head and neck cancer treatment provided free
This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab after surgery in treating patients with high-risk stage III-IV head and neck cancer the begins in the thin, flat cells (squamous cell). Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as cisplatin and docetaxel, wor
Sponsor: National Cancer Institute (NCI)
Check if you qualify for this head and neck cancer clinical trial in Birmingham, AL
If you're searching for head and neck cancer treatment options in Birmingham, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced head and neck cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.